Share Prices & Company Research

Market News

05 Mar 2019 | 14:09

Eco Animal Health gets regulatory nod in India for chicken egg treatment

Eco Animal Health Group said it had received a marketing authorisation from Indian authorities for use of its antimicrobial treatment in chickens laying eggs for human consumption.

The approval allowed the company to start selling its Aivlosin treatment in India for the medication of drinking water for the treatment of infections caused by Mycoplasma in eggs.

Aivlosin was used under veterinary prescription for the treatment of a variety of economically important respiratory and gut diseases in poultry and pigs.

'India is ranked second with just over 5% of the world's laying birds and although the market is somewhat fragmented, we expect this to change in the future,' chairman Peter Lawrence said.

'This latest approval demonstrates ECO's continued progress in rolling out this indication for commercial layers.'

At 2:09pm: (LON:EAH) Eco Animal Health Group PLC share price was +5p at 460p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.